Page last updated: 2024-12-08

acyloin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID162822
SCHEMBL ID1786126
MeSH IDM0057254

Synonyms (11)

Synonym
acyloin
3-hydroxy-octadecane-2-one
57419-49-5
2-octadecanone, 3-hydroxy-
3-hydroxyoctadecan-2-one
boc-d-serine h2o;boc-d-ser-oh; n-(tert-butoxycarbonyl)-d-serine
A22792
3-hydroxyoc-tadecan-2-one
SCHEMBL1786126
3-hydroxyoctadecane-2-one
DTXSID50972905

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (44)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (11.36)18.7374
1990's6 (13.64)18.2507
2000's14 (31.82)29.6817
2010's14 (31.82)24.3611
2020's5 (11.36)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 58.46

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index58.46 (24.57)
Research Supply Index3.81 (2.92)
Research Growth Index4.79 (4.65)
Search Engine Demand Index94.94 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (58.46)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.27%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other43 (97.73%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]